Sonendo, Inc. SONX
Set alert
At close · Oct 30
- YTD
- +326.67%
- 1 year
- +392.31%
- Open
- 0.85
- Prev close
- 1.28
- Mkt cap
- 6.10M
- Vol
- 999
- Avg vol
- 213
- EPS
- -150.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.85
- High
- 0.85
- Forward P/E
- -0.29
- Beta
- 2.04
- Short ratio
- 0.61
- Inst. own
- 65.92%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.317194
- 200-d avg
- 1.11
- 1y target
- 1.71
Key statistics
- Market cap
- 7.27M
- Enterprise value
- -8.35M
- Trailing P/E
- 0.00
- Forward P/E
- -0.29
- PEG ratio
- 0.00
- Price / sales
- 0.16
- Price / book
- 0.19
- EPS (TTM)
- -0.19
- Beta
- 2.04
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -137.14%
- Revenue (TTM)
- 44.40M
- Revenue growth
- 5.70%
- Free cash flow
- -29.51M
- Total cash
- 55.94M
- Total debt
- 40.32M
- Return on equity
- -95.04%
- Shares outstanding
- 54.28M
- Short % of float
- 0.92%
- 50-day average
- 0.317194
- 200-day average
- 1.11
Analyst view
Consensus: buy
- Target (low)
- 0.40
- Target (mean)
- 1.71
- Target (high)
- 4.60
Next earnings
Consensus EPS estimate -0.14.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | -24.00 | -15.77 | +8.23 | +34.29% |
| Aug 7, 2024 | Jun 1, 2024 | -24.00 | -16.00 | +8.00 | +33.33% |
| May 8, 2024 | Mar 1, 2024 | 18.00 | -26.00 | -44.00 | -244.44% |
| Mar 11, 2024 | Dec 1, 2023 | -30.00 | -24.00 | +6.00 | +20.00% |
| Nov 8, 2023 | Sep 1, 2023 | -28.00 | -28.00 | 0.00 | 0.00% |
| Aug 9, 2023 | Jun 1, 2023 | -30.00 | -38.00 | -8.00 | -26.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 10, 2023 | Goldman Sachs | main | Buy | Buy |
| Aug 9, 2023 | Goldman Sachs | main | Buy | Buy |
| Aug 9, 2023 | Piper Sandler | down | Overweight | Neutral |
| May 10, 2023 | Goldman Sachs | main | Buy | Buy |
| May 9, 2023 | Morgan Stanley | main | — | Equal-Weight |
| Mar 12, 2023 | Goldman Sachs | main | — | Buy |
About Sonendo, Inc.
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- sonendo.com
News
- Sonendo (NYSE:SONX) Stock Price Up 6.2% – What’s Next?
- Sonendo Achieves Milestone of Two Million Patients Treated with the GentleWave® Procedure
- Sonendo Announces Key Initiatives to Drive Business Towards Cashflow Break-Even
- Sonendo, Inc. on Path to Breakeven in the Second Half of 2026
- Sonendo (NYSE:SONX) Shares Up 475% – Here’s Why
- Sonendo (NYSE:SONX) Trading Up 3.5% – Time to Buy?
- Sonendo (NYSE:SONX) Trading Up 3.8% – Here’s Why
- Sonendo Strengthens Leadership Team With Promotion of John McGaugh to Chief Operating Officer
- Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance
- Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance
Your note
Sign in to keep a note on SONX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEAVER CAROLYN D | Director | Stock Award(Grant) | Jun 15, 2023 | 62,798 |
| BERGHEIM BJARNE | Chief Executive Officer | Sale | Jun 15, 2023 | 2,042,360 |
| BERGHEIM OLAV B | Director | Purchase | Nov 15, 2023 | 0 |
| BIHL ANTHONY P III | Director | Stock Award(Grant) | Jun 15, 2023 | 125,998 |
| CHEN ROY T | Officer | Sale | Sep 10, 2023 | 308,152 |
| MCGINNIS KAREN K | Director | Stock Award(Grant) | Jun 15, 2023 | 59,998 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ArrowMark Colorado Holdings LLC | 11.30% | 5,955,911 | 8.10M | Jun 29, 2023 |
| Pura Vida Investments, Llc | 8.87% | 4,672,145 | 6.35M | Jun 29, 2023 |
| Blue Water Life Science Advisors, Lp | 8.81% | 4,643,461 | 6.32M | Jun 29, 2023 |
| First Light Asset Management, LLC | 7.94% | 4,185,619 | 5.69M | Jun 29, 2023 |
| Driehaus Capital Management, LLC | 7.29% | 3,843,051 | 5.23M | Jun 29, 2023 |
| Vanguard Group Inc | 3.84% | 2,024,403 | 2.75M | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Meridian Small Cap Growth Fund | 7.41% | 3,904,929 | 5.31M | Jun 29, 2023 |
| Vanguard Total Stock Market Index Fund | 2.79% | 1,470,409 | 2.00M | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.84% | 441,583 | 600.55K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.37% | 196,292 | 249.29K | May 30, 2023 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.34% | 181,500 | 246.84K | Jun 29, 2023 |
| SEI Institutional Managed Tr-Small Cap Growth Fund | 0.31% | 161,953 | 120.78K | Sep 29, 2023 |